BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28525363)

  • 21. Human papillomavirus prevalence is high in oral samples of patients with tonsillar and base of tongue cancer.
    Nordfors C; Vlastos A; Du J; Ahrlund-Richter A; Tertipis N; Grün N; Romanitan M; Haeggblom L; Roosaar A; Dahllöf G; Donà MG; Benevolo M; Ramqvist T; Munck-Wikland E; Dalianis T
    Oral Oncol; 2014 May; 50(5):491-7. PubMed ID: 24613649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in gene expression between high-grade dysplasia and invasive HPV
    Haeggblom L; Ährlund-Richter A; Mirzaie L; Farrajota Neves da Silva P; Ursu RG; Ramqvist T; Näsman A
    Cancer Med; 2019 Oct; 8(14):6221-6232. PubMed ID: 31454186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-A*02 in relation to outcome in human papillomavirus positive tonsillar and base of tongue cancer.
    Tertipis N; Villabona L; Nordfors C; Näsman A; Ramqvist T; Vlastos A; Masucci G; Dalianis T
    Anticancer Res; 2014 May; 34(5):2369-75. PubMed ID: 24778045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations.
    Holzhauser S; Wild N; Zupancic M; Ursu RG; Bersani C; Näsman A; Kostopoulou ON; Dalianis T
    Front Oncol; 2021; 11():640490. PubMed ID: 34046344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors for head and neck cancer of unknown primary including the impact of human papilloma virus infection.
    Axelsson L; Nyman J; Haugen-Cange H; Bove M; Johansson L; De Lara S; Kovács A; Hammerlid E
    J Otolaryngol Head Neck Surg; 2017 Jun; 46(1):45. PubMed ID: 28601094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3.
    Weberpals JI; Lo B; Duciaume MM; Spaans JN; Clancy AA; Dimitroulakos J; Goss GD; Sekhon HS
    Clin Cancer Res; 2017 Aug; 23(15):4501-4510. PubMed ID: 28377483
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical features and expressions of p16, p53 protein of human papillomavirus-related tonsillar carcinoma].
    Zhang Y; Zhang B; Zhou H; Liu W; Chen W; Xu Z
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Feb; 50(2):131-7. PubMed ID: 25916534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of Human Papillomavirus as a Favourable Prognostic Marker and Analysis of CD8
    Sivars L; Landin D; Grün N; Vlastos A; Marklund L; Nordemar S; Ramqvist T; Munck-Wikland E; Näsman A; Dalianis T
    Anticancer Res; 2017 Feb; 37(2):665-673. PubMed ID: 28179315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets.
    Zięba S; Kowalik A; Zalewski K; Rusetska N; Goryca K; Piaścik A; Misiek M; Bakuła-Zalewska E; Kopczyński J; Kowalski K; Radziszewski J; Bidziński M; Góźdź S; Kowalewska M
    Gynecol Oncol; 2018 Sep; 150(3):552-561. PubMed ID: 29980281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil.
    Na II; Kang HJ; Cho SY; Koh JS; Lee JK; Lee BC; Lee GH; Lee YS; Yoo HJ; Ryoo BY; Yang SH; Shim YS
    Eur J Cancer; 2007 Feb; 43(3):520-6. PubMed ID: 17224267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations.
    Strome SE; Savva A; Brissett AE; Gostout BS; Lewis J; Clayton AC; McGovern R; Weaver AL; Persing D; Kasperbauer JL
    Clin Cancer Res; 2002 Apr; 8(4):1093-100. PubMed ID: 11948119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer.
    Hoffmann M; Ihloff AS; Görögh T; Weise JB; Fazel A; Krams M; Rittgen W; Schwarz E; Kahn T
    Int J Cancer; 2010 Oct; 127(7):1595-602. PubMed ID: 20091864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV status in unknown primary head and neck cancer: Prognosis and treatment outcomes.
    Cheraghlou S; Torabi SJ; Husain ZA; Otremba MD; Osborn HA; Mehra S; Yarbrough WG; Burtness BA; Judson BL
    Laryngoscope; 2019 Mar; 129(3):684-691. PubMed ID: 30151832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors.
    Kostopoulou ON; Zupancic M; Pont M; Papin E; Lukoseviciute M; Mikelarena BA; Holzhauser S; Dalianis T
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A model using concomitant markers for predicting outcome in human papillomavirus positive oropharyngeal cancer.
    Bersani C; Mints M; Tertipis N; Haeggblom L; Sivars L; Ährlund-Richter A; Vlastos A; Smedberg C; Grün N; Munck-Wikland E; Näsman A; Ramqvist T; Dalianis T
    Oral Oncol; 2017 May; 68():53-59. PubMed ID: 28438294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIPK2 Overexpression and Its Prognostic Role in Human Papillomavirus-Positive Tonsillar Squamous Cell Carcinoma.
    Kwon MJ; Kang SY; Nam ES; Cho SJ; Rho YS
    Biomed Res Int; 2017; 2017():1056427. PubMed ID: 28607924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomes.
    Alsofyani AA; Dallol A; Farraj SA; Alsiary RA; Samkari A; Alhaj-Hussain BT; Khan JA; Al-Maghrabi J; Al-Khayyat SS; Alkhatabi H; Elaimi A; Buhmeida A; Johargy AK; Abuzenadah AM; Azhar EI; Al-Qahtani MH
    Cancer Biomark; 2020; 28(2):213-220. PubMed ID: 32250288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-Treatment Neck Dissection of Tonsillar and Base of Tongue Squamous Cell Carcinoma in the Era of PET-CT, HPV, and p16.
    Landin D; Näsman A; Jara SJ; Hammarstedt-Nordenvall L; Munck-Wikland E; Dalianis T; Marklund L
    Viruses; 2022 Jul; 14(8):. PubMed ID: 36016315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.
    Lim SM; Cho SH; Hwang IG; Choi JW; Chang H; Ahn MJ; Park KU; Kim JW; Ko YH; Ahn HK; Cho BC; Nam BH; Chun SH; Hong JH; Kwon JH; Choi JG; Kang EJ; Yun T; Lee KW; Kim JH; Kim JS; Lee HW; Kim MK; Jung D; Kim JE; Keam B; Yun HJ; Kim S; Kim HR
    Cancer Res Treat; 2019 Jan; 51(1):300-312. PubMed ID: 29747488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MHC class I expression in HPV positive and negative tonsillar squamous cell carcinoma in correlation to clinical outcome.
    Näsman A; Andersson E; Nordfors C; Grün N; Johansson H; Munck-Wikland E; Massucci G; Dalianis T; Ramqvist T
    Int J Cancer; 2013 Jan; 132(1):72-81. PubMed ID: 22592660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.